Literature DB >> 3538372

Chemical composition of antigen 60 from Mycobacterium bovis BCG.

I Fabre, O L'Homme, M Bruneteau, G Michel, C Cocito.   

Abstract

Antigen 60 (A60), the main thermostable immunogen of tuberculin and PPD, has been purified from Mycobacterium bovis BCG cytoplasm, and identified by crossed immunoelectrophoresis with anti-BCG polyclonal antiserum. Two A60 fractions, free lipids and lipid-conjugated compounds, have been recognized. The free lipids represented about 30% (dry weight), and consisted essentially of C16-C18 fatty acids, and of phosphatidyl-inositol-mannosides. Lipoconjugates, upon DEAE-cellulose chromatography and gel filtration, yielded two main fractions of neutral and polar components. Chromatography of delipidated and deproteinized A60 on Sephadex G-100 yielded: a high molecular weight fraction (Al, 18%, a lipoglucan of congruent to 10(6)), and a low molecular weight fraction (B, 10%, a lipopeptidoglycan of congruent to 10(4)) containing mannose, glucose, and small amounts of arabinose. The polysaccharide moieties of fractions Al and B were submitted to acetylation, methylation, and acid hydrolysis, and the structure of the hydrolysed polymer was deduced by combined gas chromatography/mass spectrometry analysis. The results indicated a branched structure involving 1,4-, 1,6-, and 1,4,6-linked D-gluco- or D-manno-pyranosyl residues. Glucan- and peptidoglycan-bound fatty acids were identified as saturated (C16-C18) and monounsaturated linear acids (C12-C18). Immunodiffusion on agarose gel indicated that delipidation and proteolysis did not suppress the ability of A60 to yield immunoprecipitates with anti-A60 antiserum. The high polymer fractions obtained by chromatography on DEAE cellulose and Sephadex G-100 were also reactive. It is concluded that A60 is made of free lipids and of lipopeptidoglycans of high molecular weights (10(6)-10(7)) endowed with immunogenic properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538372     DOI: 10.1111/j.1365-3083.1986.tb02175.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  16 in total

1.  Public health application of a serological test for tuberculosis: study of the incidence of inapparent infections among the employees of an Alsatian supermarket.

Authors:  C Wirrmann
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study.

Authors:  C J Sindic; D Boucquey; M P Van Antwerpen; M C Baelden; C Laterre; C Cocito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

3.  Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Authors:  R D Hubbard; C M Flory; F M Collins; C Cocito
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Composition and immunogenicity of the polysaccharide components of the thermostable macromolecular antigen group of mycobacterial antigens.

Authors:  M Bruneteau; J Perret; F Vanlinden; G Michel; C Cocito
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

5.  Subcellular localisation and sedimentation behaviour of antigen 60 from Mycobacterium bovis BCG.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

6.  Delayed hypersensitivity reactions by the mycobacterial antigen A60 and cutaneous testing in tuberculosis.

Authors:  C Benoit; A Beschin; M Desmecht; P Dekeyser; C Cocito
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

7.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

8.  Serological response of tuberculosis patients to antigen 60 of BCG.

Authors:  M J Gevaudan; C Bollet; D Charpin; M N Mallet; P De Micco
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

9.  Metabolism of the TMA group of antigens during the growth cycle of mycobacteria.

Authors:  C Cocito; F Vanlinden
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

10.  Comparative cutaneous testing with purified protein derivative and the antigen complex A60 in vaccinated subjects and tuberculosis patients.

Authors:  Y L Zou; J D Zhang; M H Chen; G Q Shi; C Cocito
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.